Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The GETAFIX trial will test the hypothesis that favipiravir is a more effective treatment for COVID-19 infection in patients who have early stage disease, compared to current standard of care. This study will also provide an important opportunity to investigate the safety and tolerabilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Catherine R., Blyth, Kevin G., Burley, Glenn, Carmichael, Samantha, Evans, Carol, Hinsley, Samantha, Khadra, Ibrahim, Khoo, Saye, Lewsley, Liz-Anne, Jones, Robert R., Sharma, Raman, Taladriz-Sender, Andrea, Thomson, Emma C., Scott, Janet T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675389/
https://www.ncbi.nlm.nih.gov/pubmed/33213530
http://dx.doi.org/10.1186/s13063-020-04891-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675389/
https://www.ncbi.nlm.nih.gov/pubmed/33213530
http://dx.doi.org/10.1186/s13063-020-04891-1

Ejemplares similares